Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1978 Jun;91(3):571–580.

Fine structural alterations induced in erythocytes by phorbol myristate acetate.

J G White, J E Repine
PMCID: PMC2018318  PMID: 655263

Abstract

Prevous studies have demonstrated that PMA is a potent membrane-active agent causing cell-wall derived vacuole formation in neutrophils and granule labilization in platelets. The present investigation demonstrates that PMA also has marked effects on red blood cells. Erythrocytes exposed to PMA were converted into stomatocytes and stomatospherocytes. The effects of PMA on red cells were concentration-dependent, required removal of plasma, and occurred maximally at 37 C. Although the response of the red cell to PMA was not identical to that of other blood cells tested previously; the similarities suggest that the capacity of the agent to produce membrane invagination may be fundamental to its mode of action.

Full text

PDF
571

Images in this article

579Figure A
on p.579
579Figure B
on p.579
579Figure C
on p.579
579Figures D,E,F
on p.579
579Figures G,H,I
on p.579
579Figures J,K,L
on p.579
579Figures M,N,O
on p.579
580Figures P,Q,R,S,T,U
on p.580

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Deuticke B. Transformation and restoration of biconcave shape of human erythrocytes induced by amphiphilic agents and changes of ionic environment. Biochim Biophys Acta. 1968 Dec 10;163(4):494–500. doi: 10.1016/0005-2736(68)90078-3. [DOI] [PubMed] [Google Scholar]
  2. Estensen R. D., White J. G., Holmes B. Specific degranulation of human polymorphonuclear leukocytes. Nature. 1974 Mar 22;248(446):347–348. doi: 10.1038/248347a0. [DOI] [PubMed] [Google Scholar]
  3. Hecker E. Cocarcinogenic principles from the seed oil of Croton tiglium and from other Euphorbiaceae. Cancer Res. 1968 Nov;28(11):2338–2349. [PubMed] [Google Scholar]
  4. Hecker E. Phorbol esters from croton oil. Chemical nature and biological activities. Naturwissenschaften. 1967 Jun;54(11):282–284. doi: 10.1007/BF00620887. [DOI] [PubMed] [Google Scholar]
  5. Hennings H., Boutwell R. K. Studies on the mechanism of skin tumor promotion. Cancer Res. 1970 Feb;30(2):312–320. [PubMed] [Google Scholar]
  6. Rao G. H., White J. G. Influence of esterase inhibitors on platelet aggregation and release induced by phorbol myristate acetate. Biochem Pharmacol. 1975 Jan 15;24(2):293–295. doi: 10.1016/0006-2952(75)90292-0. [DOI] [PubMed] [Google Scholar]
  7. Repine J. E., White J. G., Clawson C. C., Holmes B. M. Effects of phorbol myristate acetate on the metabolism and ultrastructure of neutrophils in chronic granulomatous disease. J Clin Invest. 1974 Jul;54(1):83–90. doi: 10.1172/JCI107752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Repine J. E., White J. G., Clawson C. C., Holmes B. M. The influence of phorbol myristate acetate on oxygen consumption by polymorphonuclear leukocytes. J Lab Clin Med. 1974 Jun;83(6):911–920. [PubMed] [Google Scholar]
  9. Sheetz M. P., Painter R. G., Singer S. J. Biological membranes as bilayer couples. III. Compensatory shape changes induced in membranes. J Cell Biol. 1976 Jul;70(1):193–203. doi: 10.1083/jcb.70.1.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Sheetz M. P., Singer S. J. Biological membranes as bilayer couples. A molecular mechanism of drug-erythrocyte interactions. Proc Natl Acad Sci U S A. 1974 Nov;71(11):4457–4461. doi: 10.1073/pnas.71.11.4457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Sivak A., Van Duuren B. L. Cellular interactions of phorbol myristate acetate in tumor promotion. Chem Biol Interact. 1971 Nov;3(6):401–411. doi: 10.1016/0009-2797(71)90001-9. [DOI] [PubMed] [Google Scholar]
  12. Van Duuren B. L. Tumor-promoting agents in two-stage carcinogenesis. Prog Exp Tumor Res. 1969;11:31–68. doi: 10.1159/000391388. [DOI] [PubMed] [Google Scholar]
  13. Weed R. I., Bessis M. The discocyte-stomatocyte equilibrium of normal and pathologic red cells. Blood. 1973 Mar;41(3):471–475. [PubMed] [Google Scholar]
  14. Weissmann G., Troll W., Van Duuren B. L., Sessa G. Studies on lysosomes. X. Effects of tumor-promoting agents upon biological and artificial membrane systems. Biochem Pharmacol. 1968 Dec;17(12):2421–2434. doi: 10.1016/0006-2952(68)90132-9. [DOI] [PubMed] [Google Scholar]
  15. White J. G. Effects of an ionophore, A23187, on the surface morphology of normal erythrocytes. Am J Pathol. 1974 Dec;77(3):507–518. [PMC free article] [PubMed] [Google Scholar]
  16. White J. G., Estensen R. D. Selective labilization of specific granules in polymorphonuclear leukocytes by phorbol myristate acetate. Am J Pathol. 1974 Apr;75(1):45–60. [PMC free article] [PubMed] [Google Scholar]
  17. White J. G., Rao G. H., Estensen R. D. Investigation of the release reaction in platelets exposed to phorbol myristate acetate. Am J Pathol. 1974 May;75(2):301–314. [PMC free article] [PubMed] [Google Scholar]
  18. White J. G. Scanning electron microscopy of erythrocyte deformation: the influence of a calcium ionophore, A23187. Semin Hematol. 1976 Apr;13(2):121–132. [PubMed] [Google Scholar]
  19. Zucker M. B., Troll W., Belman S. The tumor-promoter phorbol ester (12-O-tetradecanoyl-phorbol-13-acetate), a potent aggregating agent for blood platelets. J Cell Biol. 1974 Feb;60(2):325–336. doi: 10.1083/jcb.60.2.325. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES